Expanding horizons in complement drug discovery: challenges and emerging strategies
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expanding horizons in complement drug discovery: challenges and emerging strategies
Authors
Keywords
Complement, Drug discovery, Therapeutics, Eculizumab, Disease, Inflammation
Journal
Seminars in Immunopathology
Volume 40, Issue 1, Pages 125-140
Publisher
Springer Nature
Online
2017-10-06
DOI
10.1007/s00281-017-0655-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Delivering advanced therapies: the big pharma approach
- (2017) J Tarnowski et al. GENE THERAPY
- Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis
- (2017) David R.W. Jayne et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Regulator-dependent mechanisms of C3b processing by factor I allow differentiation of immune responses
- (2017) Xiaoguang Xue et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- C3 glomerulopathy and eculizumab: a report on four paediatric cases
- (2017) Célia Lebreton et al. PEDIATRIC NEPHROLOGY
- Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration
- (2017) Brian L. Yaspan et al. Science Translational Medicine
- Therapeutic Inhibition of Complement: Well Worth the Risk
- (2017) Scott R. Barnum TRENDS IN PHARMACOLOGICAL SCIENCES
- A double-blind randomised controlled investigation into the efficacy of Mirococept (APT070) for preventing ischaemia reperfusion injury in the kidney allograft (EMPIRIKAL): study protocol for a randomised controlled trial
- (2017) Theodoros Kassimatis et al. Trials
- Regulator-dependent mechanisms of C3b processing by factor I allow differentiation of immune responses
- (2017) Xiaoguang Xue et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Long lasting neutralization of C5 by SKY59, a novel recycling antibody, is a potential therapy for complement-mediated diseases
- (2017) Taku Fukuzawa et al. Scientific Reports
- Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome
- (2016) Xuan Yuan et al. HAEMATOLOGICA
- Inhibition of the alternative complement pathway by antisense oligonucleotides targeting complement factor B improves lupus nephritis in mice
- (2016) Tamar R. Grossman et al. IMMUNOBIOLOGY
- Selectivity of C3-opsonin targeted complement inhibitors: A distinct advantage in the protection of erythrocytes from paroxysmal nocturnal hemoglobinuria patients
- (2016) Christoph Q. Schmidt et al. IMMUNOBIOLOGY
- Sweeping antibody as a novel therapeutic antibody modality capable of eliminating soluble antigens from circulation
- (2016) Tomoyuki Igawa et al. IMMUNOLOGICAL REVIEWS
- Small-molecule factor D inhibitors targeting the alternative complement pathway
- (2016) Jürgen Maibaum et al. Nature Chemical Biology
- Complement in disease: a defence system turning offensive
- (2016) Daniel Ricklin et al. Nature Reviews Nephrology
- Structural basis for therapeutic inhibition of complement C5
- (2016) Matthijs M Jore et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Complement inhibition in C3 glomerulopathy
- (2016) Carla M. Nester et al. SEMINARS IN IMMUNOLOGY
- New therapeutic and diagnostic opportunities for injured tissue-specific targeting of complement inhibitors and imaging modalities
- (2016) V. Michael Holers et al. SEMINARS IN IMMUNOLOGY
- Structural basis for therapeutic inhibition of complement C5
- (2016) Matthijs M Jore et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome
- (2016) Xuan Yuan et al. HAEMATOLOGICA
- Advances in Therapeutic Fc Engineering – Modulation of IgG-Associated Effector Functions and Serum Half-life
- (2016) Abhishek Saxena et al. Frontiers in Immunology
- Targeting Pathogenic Postischemic Self-Recognition by Natural IgM to Protect Against Posttransplantation Cardiac Reperfusion InjuryCLINICAL PERSPECTIVE
- (2015) Carl Atkinson et al. CIRCULATION
- Molecules Great and Small: The Complement System
- (2015) D. R. Mathern et al. Clinical Journal of the American Society of Nephrology
- Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention
- (2015) Dimitrios C. Mastellos et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Age-related macular degeneration: genome-wide association studies to translation
- (2015) James R. M. Black et al. GENETICS IN MEDICINE
- Rare genetic variants in the CFI gene are associated with advanced age-related macular degeneration and commonly result in reduced serum factor I levels
- (2015) D. Kavanagh et al. HUMAN MOLECULAR GENETICS
- Inhibitory FcγRIIb-Mediated Soluble Antigen Clearance from Plasma by a pH-Dependent Antigen-Binding Antibody and Its Enhancement by Fc Engineering
- (2015) Yuki Iwayanagi et al. JOURNAL OF IMMUNOLOGY
- Gene therapy returns to centre stage
- (2015) Luigi Naldini NATURE
- Complement, a target for therapy in inflammatory and degenerative diseases
- (2015) B. Paul Morgan et al. NATURE REVIEWS DRUG DISCOVERY
- An anticomplement agent that homes to the damaged brain and promotes recovery after traumatic brain injury in mice
- (2015) Marieta M. Ruseva et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Complement and Its Receptors: New Insights into Human Disease
- (2014) V. Michael Holers Annual Review of Immunology
- pH-dependent antigen-binding antibodies as a novel therapeutic modality
- (2014) T. Igawa et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Assessing complement blockade in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab
- (2014) R. Peffault de Latour et al. BLOOD
- A Humanized Antibody That Regulates the Alternative Pathway Convertase: Potential for Therapy of Renal Disease Associated with Nephritic Factors
- (2014) D. Paixao-Cavalcante et al. JOURNAL OF IMMUNOLOGY
- Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria
- (2013) Peter Hillmen et al. BRITISH JOURNAL OF HAEMATOLOGY
- Rational Engineering of a Minimized Immune Inhibitor with Unique Triple-Targeting Properties
- (2013) C. Q. Schmidt et al. JOURNAL OF IMMUNOLOGY
- Complement in Immune and Inflammatory Disorders: Pathophysiological Mechanisms
- (2013) D. Ricklin et al. JOURNAL OF IMMUNOLOGY
- Engineered Monoclonal Antibody with Novel Antigen-Sweeping Activity In Vivo
- (2013) Tomoyuki Igawa et al. PLoS One
- Postpartum aHUS Secondary to a Genetic Abnormality in Factor H Acquired Through Liver Transplantation
- (2012) J. H. Brown et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The continual presence of C3d but not IgG glomerular capillary deposition in stage I idiopathic membranous nephropathy in patients receiving corticosteroid treatment
- (2012) Rui Zhang et al. Diagnostic Pathology
- Complement dysregulation and disease: From genes and proteins to diagnostics and drugs
- (2012) Santiago Rodriguez de Cordoba et al. IMMUNOBIOLOGY
- The complotype: dictating risk for inflammation and infection
- (2012) Claire L. Harris et al. TRENDS IN IMMUNOLOGY
- Assembly and Regulation of the Membrane Attack Complex Based on Structures of C5b6 and sC5b9
- (2012) Michael A. Hadders et al. Cell Reports
- Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseases
- (2011) M. Fridkis-Hareli et al. BLOOD
- Pharmacokinetics of Anti-hepcidin Monoclonal Antibody Ab 12B9m and Hepcidin in Cynomolgus Monkeys
- (2010) Jim J. Xiao et al. AAPS Journal
- Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization
- (2010) Tomoyuki Igawa et al. NATURE BIOTECHNOLOGY
- Hereditary Angioedema — Therapies Old and New
- (2010) B. Paul Morgan NEW ENGLAND JOURNAL OF MEDICINE
- Structures of C3b in Complex with Factors B and D Give Insight into Complement Convertase Formation
- (2010) F. Forneris et al. SCIENCE
- Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab
- (2009) A. M. Risitano et al. BLOOD
- Structural and Functional Analysis of a C3b-specific Antibody That Selectively Inhibits the Alternative Pathway of Complement
- (2009) Kenneth J. Katschke et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pathogenic Natural Antibodies Recognizing Annexin IV Are Required to Develop Intestinal Ischemia-Reperfusion Injury
- (2009) L. Kulik et al. JOURNAL OF IMMUNOLOGY
- Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
- (2009) Jean-Charles Lambert et al. NATURE GENETICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started